John Reeder
Direttore/Membro del Consiglio presso Drugs for Neglected Diseases initiative
Posizioni attive di John Reeder
Società | Posizione | Inizio | Fine |
---|---|---|---|
Drugs for Neglected Diseases initiative
Drugs for Neglected Diseases initiative BiotechnologyHealth Technology Drugs for Neglected Diseases initiative provides drug research and development services. It specializes in analyzing the causes of and in developing medicine and treatments for neglected diseases. It specializes in the study of neglected tropical diseases, such as sleeping sickness (Human African Trypanosomiasis), Leishmaniasis, Chagas, malaria, pediatric HIV, and filarial diseases. It develops a research and development portfolio that includes projects from discovery through to post-registration phases. Its focus areas encompass regional disease-specific platform development, technology transfer, and public responsibility and awareness advocacies. The organization was founded in July 2003 and is headquartered in Geneva, Switzerland. | Direttore/Membro del Consiglio | - | - |
Storia della carriera di John Reeder
Precedenti posizioni note di John Reeder
Società | Posizione | Inizio | Fine |
---|---|---|---|
The Macfarlane Burnet Institute For Medical Research & Public
The Macfarlane Burnet Institute For Medical Research & Public Miscellaneous Commercial ServicesCommercial Services The Macfarlane Burnet Institute For Medical Research & Public Health Ltd. provides medical research and public health services. Its programs include maternal health, disease elimination, behaviors and health risks, health security, and healthy ageing. The organization also focuses on women's and children's health; alcohol, other drugs and harm reduction; sexual and reproductive health; and young people's health. The organization was founded in 1986 headquartered in Melbourne, Australia. | Corporate Officer/Principal | - | - |
Formazione di John Reeder
The University of Manchester | Doctorate Degree |
Statistiche
Distribuzione geografica
Svizzera | 2 |
Australia | 2 |
Israele | 2 |
Posizioni
Director/Board Member | 1 |
Corporate Officer/Principal | 1 |
Doctorate Degree | 1 |
Settori
Health Technology | 2 |
Commercial Services | 2 |
Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 2 |
---|---|
Drugs for Neglected Diseases initiative
Drugs for Neglected Diseases initiative BiotechnologyHealth Technology Drugs for Neglected Diseases initiative provides drug research and development services. It specializes in analyzing the causes of and in developing medicine and treatments for neglected diseases. It specializes in the study of neglected tropical diseases, such as sleeping sickness (Human African Trypanosomiasis), Leishmaniasis, Chagas, malaria, pediatric HIV, and filarial diseases. It develops a research and development portfolio that includes projects from discovery through to post-registration phases. Its focus areas encompass regional disease-specific platform development, technology transfer, and public responsibility and awareness advocacies. The organization was founded in July 2003 and is headquartered in Geneva, Switzerland. | Health Technology |
The Macfarlane Burnet Institute For Medical Research & Public
The Macfarlane Burnet Institute For Medical Research & Public Miscellaneous Commercial ServicesCommercial Services The Macfarlane Burnet Institute For Medical Research & Public Health Ltd. provides medical research and public health services. Its programs include maternal health, disease elimination, behaviors and health risks, health security, and healthy ageing. The organization also focuses on women's and children's health; alcohol, other drugs and harm reduction; sexual and reproductive health; and young people's health. The organization was founded in 1986 headquartered in Melbourne, Australia. | Commercial Services |
- Borsa valori
- Insiders
- John Reeder
- Esperienza